Greenville Health System Cancer Institute-Eastside — Greenville, South Carolina

Greenville Health System Cancer Institute-Eastside is a clinical research site located in Greenville, South Carolina, United States 29615.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Greenville Health System Cancer Institute-Eastside has participated in 72 clinical trials with 9 currently active.

Therapeutic areas: Stage IA Fallopian Tube Cancer, Stage IA Ovarian Cancer, Stage IB Fallopian Tube Cancer.

Sponsors: Gynecologic Oncology Group, ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Greenville Health System Cancer Institute-Eastside?

Greenville Health System Cancer Institute-Eastside has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Greenville Health System Cancer Institute-Eastside conducted?

Greenville Health System Cancer Institute-Eastside has 72 clinical trials on record, with 9 currently active. Their work covers Stage IA Fallopian Tube Cancer, Stage IA Ovarian Cancer, Stage IB Fallopian Tube Cancer.

Is Greenville Health System Cancer Institute-Eastside accredited by Crixeo Health?

Greenville Health System Cancer Institute-Eastside has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Greenville Health System Cancer Institute-Eastside?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.